H. von Recum

Leveraging Affinity Interactions to Prolong Drug Delivery of Protein Therapeutics

This paper develops protein-polymer conjugates with high-affinity adamantane caps to enable sustained drug delivery of proteins, achieving up to 65 days of release without compromising structure/function.

Predicting Drug Interactions to Unassociated Biomedical Implants Using Machine Learning Techniques and Model Polymers

The paper develops a universal model to predict drug-polymer binding affinity using machine learning and quantitative structure-activity relationships, achieving high correlation with experimental data.

Using QSAR for predictions in drug delivery

This paper develops QSAR models to predict cyclodextrin-drug affinity, showing high efficiency and accuracy for drug delivery applications.